Stroke of antiplatelet and anticoagulant therapy in patients with coronary artery disease: a meta-analysis of randomized controlled trials
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2261
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Stroke of antiplatelet and anticoagulant therapy in patients with coronary artery disease: a meta-analysis of randomized controlled trials ; volume:21 ; number:1 ; day:1 ; month:12 ; year:2021 ; pages:1-9 ; date:12.2021
BMC cardiovascular disorders ; 21, Heft 1 (1.12.2021), 1-9, 12.2021
- Urheber
-
Shao, Qiao Yu
Wang, Zhi Jian
Ma, Xiao Teng
Lin, Xu Ze
Pan, Liu
Zhou, Yu Jie
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12872-021-02384-w
- URN
-
urn:nbn:de:101:1-2022020519064965008372
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Shao, Qiao Yu
- Wang, Zhi Jian
- Ma, Xiao Teng
- Lin, Xu Ze
- Pan, Liu
- Zhou, Yu Jie
- SpringerLink (Online service)
Ähnliche Objekte (12)
Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
Dual Antiplatelet Therapy in Coronary Artery Disease
Optimal duration of dual antiplatelet therapy for coronary artery disease
Perioperative Guidelines on Antiplatelet and Anticoagulant Agents: 2022 Update
AFM investigation of APAC (antiplatelet and anticoagulant heparin proteoglycan)
When and How to Combine Antiplatelet and Anticoagulant Drugs?
Biological Control of Combined Treatment by Antiplatelet and Anticoagulant Drugs
Should dual antiplatelet therapy be used in patients following coronary artery bypass surgery? A meta-analysis of randomized controlled trials
Lower Antiplatelet Effect of Aspirin in Essential Thrombocythemia than in Coronary Artery Disease
Impact of bleeding during dual antiplatelet therapy in patients with coronary artery disease
Comparison of dual antiplatelet therapies after coronary endarterectomy combined with coronary artery bypass grafting: a cohort study
Pituitary macroadenomas: are combination antiplatelet and anticoagulant therapy contraindicated? A case report
Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
Dual Antiplatelet Therapy in Coronary Artery Disease
Optimal duration of dual antiplatelet therapy for coronary artery disease
Perioperative Guidelines on Antiplatelet and Anticoagulant Agents: 2022 Update
AFM investigation of APAC (antiplatelet and anticoagulant heparin proteoglycan)
When and How to Combine Antiplatelet and Anticoagulant Drugs?
Biological Control of Combined Treatment by Antiplatelet and Anticoagulant Drugs
Should dual antiplatelet therapy be used in patients following coronary artery bypass surgery? A meta-analysis of randomized controlled trials
Lower Antiplatelet Effect of Aspirin in Essential Thrombocythemia than in Coronary Artery Disease
Impact of bleeding during dual antiplatelet therapy in patients with coronary artery disease
Comparison of dual antiplatelet therapies after coronary endarterectomy combined with coronary artery bypass grafting: a cohort study
Pituitary macroadenomas: are combination antiplatelet and anticoagulant therapy contraindicated? A case report
Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
Dual Antiplatelet Therapy in Coronary Artery Disease
Optimal duration of dual antiplatelet therapy for coronary artery disease
Perioperative Guidelines on Antiplatelet and Anticoagulant Agents: 2022 Update
AFM investigation of APAC (antiplatelet and anticoagulant heparin proteoglycan)
When and How to Combine Antiplatelet and Anticoagulant Drugs?
Biological Control of Combined Treatment by Antiplatelet and Anticoagulant Drugs
Should dual antiplatelet therapy be used in patients following coronary artery bypass surgery? A meta-analysis of randomized controlled trials
Lower Antiplatelet Effect of Aspirin in Essential Thrombocythemia than in Coronary Artery Disease
Impact of bleeding during dual antiplatelet therapy in patients with coronary artery disease
Comparison of dual antiplatelet therapies after coronary endarterectomy combined with coronary artery bypass grafting: a cohort study